Health

Thrombosis Research Institute (TRI) Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years

- Rapidly predicts differences in risk when treated with different anticoagulants or not treated  - Crucially, risk is calculated using patient-specific measurements rather than standardised measures, providing personalised results  - Underscored by data of 52,000 AF patients and externally vali...

2019-11-21 23:05 2795

Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results

HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...

2019-11-21 20:00 5944

Synbiotic Health signs licensing agreement to enable development of unique synergistic synbiotics

LINCOLN, Nebraska, Nov. 21, 2019 /PRNewswire/ -- Synbiotics -- combinations of probiotics and prebiotics -- are a rapidly growing category of natural health products. However, researchers are only now beginning to study how synbiotics should be optimally formulated. Recently, Synbiotic Health ann...

2019-11-21 19:00 1240

Cosmoprof & Cosmopack Asia Awards

HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Cosmoprof Asia 2019, the leading B2B event for the beauty industry in theAsia-Pacific region, announced the winners of Cosmopack and Cosmoprof Asia Awards last night during the Awards Ceremony at the Hong Kong Convention and Exhibition Centre attended by s...

2019-11-21 12:50 4130

Global Cord Blood Corp Comments on New Regulation

HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in ...

2019-11-20 20:00 5619

NeuroVive Pharmaceutical AB Interim Report January - September 2019

STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Important events July - September * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study * NeuroSTAT receives Fast Track designation from the US Food and Drug Administration. Financial information third quarter (July-Septem...

2019-11-20 16:38 3939

Covance Receives 2019 Global CRO Customer Value Leadership Award from Frost & Sullivan

SINGAPORE, Nov. 20, 2019 /PRNewswire/ -- Covance was honored with the 2019 Global CRO Customer Value Leadership award from Frost & Sullivan at the annual Frost & Sullivan Asia-Pacific Best Practices Awards banquet held inSingapore on 14 November 2019. Frost & Sullivan firmly believes Covance's e...

2019-11-20 15:52 1072

Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations

- Japanese Ministry of Health, Labour and Welfare grants orphan drug designation for diseases that affect fewer than 50,000 patients inJapan, and for which significant unmet medical need exists - MET exon 14 (METex14) skipping alterations and MET amplifications are present in 3-5% of non-small c...

2019-11-20 15:00 2312

Cambridge Quantum Computing Achieves Groundbreaking Results in Quantum Chemistry

CQC gets VQE "off the ground" and provides an efficient route towards simulating excited molecules using quantum computers CAMBRIDGE, England, Nov. 20, 2019 /PRNewswire/ -- Cambridge Quantum Computing ("CQC") today announced an important breakthrough in quantum chemistry that will enhance and ac...

2019-11-20 15:00 2347

CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib

SUZHOU, China, Nov. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the first patient has been dosed in the Phase I bridging registrational study of ivosidenib (TIBSOVO®) in China. This stand-alone trial is designed to validate the effi...

2019-11-20 11:41 2304

Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications

HYDERABAD, India, Nov. 20, 2019 /PRNewswire/ -- Excelra, a leading global Data and Analytics Company today announced a Drug Repurposing collaboration withOsaka -based Maruho – a pharmaceutical company specialising in Dermatology. Under the agreement, the Drug Repurposing Data Scientists and Therap...

2019-11-20 10:00 2268

Potential New Biomarkers for Parkinson's Disease Could Change Trajectory of Diagnosis and Treatment

LONDON, Nov. 20, 2019 /PRNewswire/ -- World Federation of Neurology: A groundbreaking presentation coming out of theXXIV World Congress of Neurology (WCN 2019) inDubai, UAE, highlighted several significant advances in Parkinson's research. "We are beginning to understand Parkinson's disease mech...

2019-11-20 02:27 1047

The Geneva Association Appoints Kai-Uwe Schanz as Deputy Managing Director and Head of Research & Foresight

ZURICH, Nov. 20, 2019 /PRNewswire/ -- The Geneva Association, the global organisation of insurance and reinsurance Chief Executive Officers (CEOs) and leading think tank of the insurance industry, is announcing the appointment of Kai-Uwe Schanz as Deputy Managing Director and Head of Research & Fo...

2019-11-20 02:25 3568

LexisNexis Risk Solutions Earns Acclaim from Frost & Sullivan for Employing an Advanced Data Analytics Architecture to Aid Healthcare Decision-making

The company leverages a range of solutions to enhance the patient experience and operational efficiencies SANTA CLARA, California and ATLANTA, Nov. 19, 2019 /PRNewswire/ -- Based on its recent analysis of the US healthcare data analytics market, Frost & Sullivan recognizesLexisNexis® Risk Soluti...

2019-11-19 22:00 4613

Firmenich Proves Malodor Control Is a Key Lever in Tackling Today's Sanitation Crisis

GENEVA, Nov. 19, 2019 /PRNewswire/ -- Marking World Toilet Day, Firmenich, the world's largest privately-owned perfume and taste company, released pioneering research demonstrating that malodor control is a key lever in tackling today's sanitation crisis. The four-country study, released at the G...

2019-11-19 21:00 2718

Meet Global Exhibitors and Hear from World-renowned Speakers at CHTF2019

SHENZHEN, China, Nov. 15, 2019 /PRNewswire/ -- The 21st China Hi-Tech Fair (CHTF2019), themed "invigorating the Great Bay Area through opening up and innovation," opened onNovember 13, 2019 in Shenzhen, China. Visitors will meet leading local and global hi-tech enterprises as well as Nobel laurea...

2019-11-19 14:18 2398

Japan's #1 Exfoliator, Natural Aqua Gel Cure, Wins World Branding Award

LOS ANGELES, Nov. 19, 2019 /PRNewswire/ -- Toyo Life Service Co. Ltd., the makers ofJapan's #1 facial exfoliator Natural Aqua Gel Cure, is the recent recipient of the 2019 "Brand of the Year Award" in the Health and Beauty Category at the World Branding Awards. This is the 3rd consecutive year th...

2019-11-19 03:28 2299

A leading global medicines company executes a strategic investment in SiO2 Medical Products gaining access to a potentially disruptive novel packaging technology

* Investment confirms interest to use SiO2's technology that may provide advantages including enhanced quality and performance  * SiO2's breakthrough technology is anticipated to help provide regulatory benefits, enhanced primary packaging and potential operational savings for a range of prod...

2019-11-19 00:20 3032

Pregnancy No Longer Believed to Modify Trajectory of MS, Experts Say

LONDON, Nov. 18, 2019 /PRNewswire/ -- World Federation of Neurology — For women living with MS, pregnancy, and breastfeeding were once thought to slow the progression of the disease. During theXXIV World Congress of Neurology (WCN 2019)  inDubai, UAE, which took place Oct. 27-31, 2019, experts re...

2019-11-18 23:30 1428

The Prognosis for MS is Changing Due to Advancements in Treatment and Awareness, Yet Access to Care is Top of Mind for Global Neurologists

LONDON, Nov. 18, 2019 /PRNewswire/ -- World Federation of Neurology: Are regulators keeping up with new treatments and management strategies that can greatly improve the lives of patients with multiple sclerosis (MS)? That question is being debated following the unveiling of significant clinical ...

2019-11-18 23:28 1361
1 ... 575576577578579